SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001615774-17-007505
Filing Date
2017-12-21
Accepted
2017-12-21 13:17:54
Documents
54
Period of Report
2017-07-31
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A s108431_8ka.htm 8-K/A 27505
2 EXHIBIT 99.01 s108431_ex99-01.htm EX-99.01 161450
3 EXHIBIT 99.02 s108431_ex99-02.htm EX-99.02 147754
4 EXHIBIT 99.03 s108431_ex99-03.htm EX-99.03 307768
  Complete submission text file 0001615774-17-007505.txt   2625101

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE nspx-20170630.xml EX-101.INS 371213
6 XBRL SCHEMA FILE nspx-20170630.xsd EX-101.SCH 20832
7 XBRL CALCULATION FILE nspx-20170630_cal.xml EX-101.CAL 35268
8 XBRL DEFINITION FILE nspx-20170630_def.xml EX-101.DEF 216402
9 XBRL LABEL FILE nspx-20170630_lab.xml EX-101.LAB 153723
10 XBRL PRESENTATION FILE nspx-20170630_pre.xml EX-101.PRE 213800
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-55331 | Film No.: 171268891
SIC: 2834 Pharmaceutical Preparations